In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

How Patients Are Transforming Pharma R&D

Executive Summary

Patient-centric R&D is imperative for pharma in delivering effective medicines and better outcomes. The push to implement it is challenging long-held biopharma business practices, including how clinical trials are designed, recruited and run – and what they measure.

Advertisement

Related Content

The New World Of Pharma – Markets, Messaging And The Flash Mob
Pharma's Progress In Precision Medicine
Alzheimer's Disease: Defusing The Bomb By 2025
Investor Interest In Wearable Medical Technology Grows
PatientsLikeMe Pioneers Social Medicine
IMI Offers €12m For Patient Engagement Project
Digital Health Is Changing Health Care. Is it Changing Pharma?

Topics

Related Companies

UsernamePublicRestriction

Register

IV004513

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel